Inovio Stock Buy Hold or Sell Recommendation

INO
 Stock
  

USD 1.84  0.01  0.55%   

Considering the 90-day investment horizon and your way above-average risk tolerance, our recommendation regarding Inovio Pharmaceuticals is 'Hold'. Macroaxis provides Inovio Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding INO positions. The advice algorithm takes into account all of Inovio Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from Inovio Pharmaceuticals' buy-and-hold perspective. Please see Inovio Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Inovio and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Inovio Pharmaceuticals.

Execute Inovio Pharmaceuticals Buy or Sell Advice

The Inovio recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Inovio Pharmaceuticals. Macroaxis does not own or have any residual interests in Inovio Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Inovio Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Inovio PharmaceuticalsBuy Inovio Pharmaceuticals
Hold

Volatility

Details

Hype Condition

Details

Current Valuation

Details

Odds of Distress

Details

Economic Sensitivity

Details

Analyst Consensus

Details

Financial Strenth (F Score)

Details

Financial Leverage

Inapplicable
Details

Reporting Quality (M-Score)

Details
For the selected time horizon Inovio Pharmaceuticals has a Risk Adjusted Performance of (0.006177), Jensen Alpha of (0.18), Total Risk Alpha of (0.25) and Treynor Ratio of (0.025942)
We provide advice to complement the regular expert consensus on Inovio Pharmaceuticals. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Inovio Pharmaceuticals is not overpriced, please check out all Inovio Pharmaceuticals fundamentals, including its revenue, cash flow from operations, current asset, as well as the relationship between the cash per share and beta . Please also validate Inovio Pharmaceuticals price to earning to confirm your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Inovio Pharmaceuticals Trading Alerts and Improvement Suggestions

Inovio Pharmaceuticals generated a negative expected return over the last 90 days
Inovio Pharmaceuticals has high historical volatility and very poor performance
Inovio Pharmaceuticals may become a speculative penny stock
The company reported the last year's revenue of 1.77 M. Reported Net Loss for the year was (303.66 M) with loss before taxes, overhead, and interest of (247.47 M).
Inovio Pharmaceuticals has about 348.13 M in cash with (215.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.4.
Inovio Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: INOVIO Provides an Update on Lassa Fever and MERS Programs - Marketscreener.com

Inovio Pharmaceuticals Returns Distribution Density

The distribution of Inovio Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Inovio Pharmaceuticals' future price movements. The chart of the probability distribution of Inovio Pharmaceuticals stock daily returns describes the distribution of returns around its average expected value. We use Inovio Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Inovio Pharmaceuticals returns is essential to provide solid investment advice for Inovio Pharmaceuticals.
Mean Return-0.05Value At Risk-8.24
Potential Upside7.93Standard Deviation5.08
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Inovio Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Inovio Pharmaceuticals Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure(10.29 M)(2.09 M)(987.93 K)(1.52 M)(1.23 M)(1.33 M)
Depreciation Amortization and Accretion3.47 M5 M5.52 M4.63 M4.73 M4.39 M
Net Cash Flow or Change in Cash and Cash Equivalents4.65 M(92.95 K)(1.5 M)228.53 M(179.58 M)(184.31 M)
Issuance Purchase of Equity Shares94.35 M29.23 M9.2 M466.76 M216.11 M233.17 M
Net Cash Flow from Financing95.69 M31.04 M105.4 M465.28 M211.5 M228.2 M
Net Cash Flow from Investing(27.83 M)42.42 M(9.04 M)(58.8 M)(175.34 M)(179.96 M)
Net Cash Flow Investment Acquisitions and Disposals(18.54 M)44.5 M(8.06 M)(93.23 M)(174.11 M)(178.7 M)
Net Cash Flow from Operations(63.21 M)(73.55 M)(97.85 M)(177.98 M)(215.71 M)(221.39 M)
Share Based Compensation13.07 M10.65 M10.9 M15.65 M26.34 M28.42 M

Inovio Pharmaceuticals Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Inovio Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Inovio Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Inovio stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-0.18
β
Beta against NYSE Composite2.13
σ
Overall volatility
5.10
Ir
Information ratio -0.02

Inovio Pharmaceuticals Volatility Alert

Inovio Pharmaceuticals exhibits very low volatility with skewness of 0.49 and kurtosis of 0.91. However, we advise investors to further study Inovio Pharmaceuticals technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Inovio Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Inovio Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Inovio Pharmaceuticals Implied Volatility

Inovio Pharmaceuticals' implied volatility exposes the market's sentiment of Inovio Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Inovio Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Inovio Pharmaceuticals stock will not fluctuate a lot when Inovio Pharmaceuticals' options are near their expiration.

Inovio Pharmaceuticals Fundamentals Vs Peers

Comparing Inovio Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Inovio Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Inovio Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Inovio Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Inovio Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Inovio Pharmaceuticals by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Inovio Pharmaceuticals to competition
FundamentalsInovio PharmaceuticalsPeer Average
Return On Equity(0.92) %(0.31) %
Return On Asset(0.43) %(0.14) %
Operating Margin(28.89) %(5.51) %
Current Valuation244.54 M16.62 B
Shares Outstanding249.49 M571.82 M
Shares Owned by Insiders1.52 %10.09 %
Shares Owned by Institutions47.80 %39.21 %
Number of Shares Shorted46.15 M4.71 M
Price to Earning(5.43) X28.72 X
Price to Book1.85 X9.51 X
Price to Sales41.82 X11.42 X
Revenue1.77 M9.43 B
Gross Profit(247.47 M)27.38 B
EBITDA(296.99 M)3.9 B
Net Income(303.66 M)570.98 M
Cash and Equivalents348.13 M2.7 B
Cash per Share1.40 X5.01 X
Total Debt14.96 M5.32 B
Debt to Equity0.11 %48.70 %
Current Ratio3.17 X2.16 X
Book Value Per Share1.07 X1.93 K
Cash Flow from Operations(215.71 M)971.22 M
Short Ratio6.75 X4.00 X
Earnings Per Share(1.54) X3.12 X
Target Price2.25
Number of Employees31718.84 K
Beta1.01-0.15
Market Capitalization459.06 M19.03 B
Total Asset495.94 M29.47 B
Retained Earnings(759.25 M)9.33 B
Working Capital140.38 M1.48 B
Current Asset171.85 M9.34 B
Current Liabilities31.47 M7.9 B
   Exercise or conversion by David Weiner of 11875 shares of Inovio Pharma subject to Rule 16b-3 [view details]

About Inovio Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Inovio Pharmaceuticals? Buying financial instruments such as Inovio Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2019 2020 2021 2022 (projected)
Accounts Payable7.65 M1.47 M24.76 M26.72 M
Receivables700.07 K18.56 M5.47 M5.15 M

Use Investing Ideas to Build Portfolios

In addition to having Inovio Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Realty Thematic Idea Now

Realty
Realty Theme
Funds or Etfs investing in real estate backed instruments or issues backed by different types of commercial properties. The Realty theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Realty Theme or any other thematic opportunities.
View All  Next Launch
Please see Inovio Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for analysis

When running Inovio Pharmaceuticals price analysis, check to measure Inovio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inovio Pharmaceuticals is operating at the current time. Most of Inovio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Inovio Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inovio Pharmaceuticals' price. Additionally, you may evaluate how the addition of Inovio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Is Inovio Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
459.1 M
Quarterly Revenue Growth YOY
30.382
Return On Assets
(0.43) 
Return On Equity
(0.92) 
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Inovio Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.